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Abstract
Different microarray techniques recently have been successfully used to investigate useful
information for cancer diagnosis at the gene expression level due to their ability to measure
thousands of gene expression levels in a massively parallel way. One important issue is to improve
classification performance of microarray data. However, it would be ideal that influential genes and
even interpretable rules can be explored at the same time to offer biological insight.
Introducing the concepts of system design in software engineering, this paper has presented an
integrated and effective method (named X-AI) for accurate cancer classification and the acquisition
of knowledge from DNA microarray data. This method included a feature selector to
systematically extract the relative important genes so as to reduce the dimension and retain as
much as possible of the class discriminatory information. Next, diagonal quadratic discriminant
analysis (DQDA) was combined to classify tumors, and generalized rule induction (GRI) was
integrated to establish association rules which can give an understanding of the relationships
between cancer classes and related genes.
Two non-redundant datasets of acute leukemia were used to validate the proposed X-AI, showing
significantly high accuracy for discriminating different classes. On the other hand, I have presented
the abilities of X-AI to extract relevant genes, as well as to develop interpretable rules. Further, a
web server has been established for cancer classification and it is freely available at http://
bioinformatics.myweb.hinet.net/xai.htm.
Background
The challenge of cancer treatment is to develop specific
therapies based on distinct tumor types, to maximize effi-
cacy and minimize toxicity. Hence, improvements in can-
cer classification have been paid more and more
attention. Recently, microarray gene expression data has
been successfully used to investigate useful information
for cancer classification at the gene expression level. One
of the earliest methods for cancer classification is the
weighted voting machine which is based on a linear
model [1]. Other methods includes hierarchical clustering
[2], machining learning [3,4], compound covariate [5],
shrunken centroids [6], partial least square [7], principal
component analysis disjoint models [8], factor mixture
models [9], consensus analysis of multiple classifiers
using non-repetitive variables [10] etc. On the whole,
these methods are mostly concentrated in the improve-
ment of accuracy rather than other issues.
In addition to classification, another challenge is to
extract relevant genes, even creditable and interpretable
rules from microarray gene expression data to offer bio-
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logical insight between genes. Several kinds of rules have
been successfully developed in different subjects of
molecular biology. In our earlier studies, decision rules
based on decision tree algorithms have been effectively
extracted from the thermodynamic database of proteins
and mutants to explore potential knowledge of protein
stability prediction [11-13]. On the other hand, associa-
tion rule techniques can also reveal relevant associations
between different items. Borgelt and Berthold [14] pre-
sented an algorithm to find fragments in a set of mole-
cules that help to discriminate between different classes of
activity in a drug discovery context. Oyama et al. [15] pro-
posed a data mining method to discover association rules
related to protein-protein interactions. Moreover, associa-
tion rules which demonstrate diverse mutations and
chemical treatments have been reported from 300 gene
expression profiles of yeast [16]. Carmona-Saez et al. [17]
have offered an approach which integrates gene annota-
tions and expression data to discover intrinsic associa-
tions.
Typically, a classification system may achieve high accu-
racy by non-linear models, but these models are hard to
provide rules. In contrast, a rule extraction system is nec-
essary to consider the model interpretability which can
provide a pathway to explore underlying relationships
among data; however, this restriction often affects the sys-
tem performance in classification. Hence, a learning
model which can provide accurate classification, as well as
useful rules, would be ideal. Even so, a relatively few
attempts have been made to integrate the two types of sys-
tems on microarray gene expression data. In earlier
reports, Li et al. [18] has proposed a classifier named PCL
(prediction by collective likelihoods) which is based on
the concept of emerging patterns and can provide the
rules describing the microarray gene expression data. Tan
et al. [19] have introduced a new classifier named TSP
(top scoring pair) which is based on relative expression
reversals and can generate accurate decision rules. These
studies also revealed the phenomenon of trade-off
between credibility and comprehensibility in such a
hybrid system. For that reason, I have made attempts to
design an integrated and effective framework with less
interaction between cancer classification and rule extrac-
tion functions.
In this paper, I have presented an integrated method
(named X-AI) which is based on a three-tiered architecture
from the viewpoint of system design of software engineer-
ing. Different tests have been carried out on two leukemia
datasets for evaluating the performance of X-AI. The
obtained results indicated that X-AI is able to perform well
on both functions of classification and rule extraction in
microarray analysis.
Materials and methods
Datasets and pre-processing
I used two different leukemia datasets for the following
reasons: (i) both datasets have been analyzed and dis-
cussed in many literatures, which is helpful to compare
with their results; (ii) the rules extracted from the similar
cancer type of datasets could be compared to each other;
(iii) the robustness of classification system could be
observed by the datasets that are obtained from different
experiments; and (iv) the two datasets represent the
nature of the binary classification and multi-class prob-
lems, which is useful to evaluate the effectiveness of the
proposed method for different classification problems.
The first acute leukemia data (named L1) of Golub et al.
[1] is composed of 72 samples from two different types of
acute leukemia, acute lymphoblastic leukemia (ALL) and
acute myeloid leukemia (AML). The training set has 38
bone marrow samples (27 ALL and 11 AML) and the test
set consists of 24 bone marrow and 10 peripheral blood
samples (20 ALL and 14 AML). Bone marrow mononu-
clear cells were collected by Ficoll sedimentation in the
training set and RNA was hybridized to Affymetrix oligo-
nucleotide microarrays, by which each sample has expres-
sion patterns of 7129 probes measured. The second acute
leukemia data (named L2) of Armstrong et al. [20]
includes 12582 gene expression values for 57 peripheral
blood or bone marrow samples. The training set contains
57 leukemia samples (20 ALL, 17 MLL (mixed lineage
leukemia) and 20 AML) and the test set contains 15 sam-
ples (4 ALL, 3 MLL and 8 AML). For microarray data, pre-
processing is of critical importance in downstream analy-
ses. In order to equalize expression values for each sample
and avoid the bias against samples, all values in a sample
have been re-scaled by a multiplicative factor which is
determined by linear regression of genes with present
calls. All multiplicative factors are available on the estab-
lished web server. Duoit et al. [21] applied thresholding,
filtering and logarithmic transformation steps before ana-
lyzing the leukemia dataset. Accordingly, the expression
values were limited by both upper and lower bounds.
Since it could be easy to neglect information leakage
effects during pre-processing of the proteomic profiling
on mass spectrometry data as well as the microarray
expression data [22], the upper bound is lifted to 24000
and the lower bound -800, which can increase the changes
of finding relevant genes due to a larger search space. Fur-
ther, I tried to perform the feature selection function
instead of a simple filter to systematically reduce the
number of genes. The mechanism is described in the fol-
lowing section.
More details of datasets can be found on the web server
and in Broad Institute http://www.broad.mit.edu which
evolved from research collaborations in the MIT and Har-Journal of Biomedical Science 2009, 16:25 http://www.jbiomedsci.com/content/16/1/25
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vard communities and made the generated data available
to the scientific community.
X-AI Method
From the viewpoint of system design in software engineer-
ing, Yourdon and Constantine [23] made a major contri-
bution to the development of structured design methods
by defining a series of criteria that can be used in separat-
ing systems into appropriate modules. Modules with tight
cohesion and loose coupling are the goal of design. Tight
cohesion means that a module should capture one
abstraction, while loose coupling means that modules
should have little dependency on each other. Introducing
the concepts, I adopted a three-tiered architecture (see Fig-
ure 1) for the integrated system and each layer includes
one or more specific functions: (i) The data management
layer comprises the functions required at all stages of data
pre-processing issues in microarray analysis. This is con-
sistent with the report of Tinker et al. [24], describing the
data management is necessary for the pre-processing
which is an important part of microarray experimenta-
tion. (ii) The data reduction layer corresponds to the fea-
ture selection function, which is mainly to reflect the fact
that not all genes measured from a microarray are relevant
to a particular cancer; moreover, the data reduction can
also help to reduce computational complexity. (iii) The
data mining layer satisfies the functions of different kinds
of analysis, and here is partitioned into two functions of
classification and rule extraction. The two functions based
on the same lower layer are loosely coupled and each
delivers a coherent group of services, conforming to the
design principle mentioned above.
The three-tiered architecture integrates the tasks of micro-
array data analysis from the pre-processing to the data
mining including classification and rule extraction. Each
function layer with independency can be changed inter-
nally without affecting other layers. Therefore, this archi-
tecture can provide the consistency of data to different
components of the same layer, and reduce the interaction
between layers as well as between the components of the
same layer.
The proposed X-AI method primarily implemented the
data mining and the data reduction layers of the architec-
ture, and integrated three functions: (i) feature selection,
(ii) cancer classification, and (iii) associate rule develop-
ment (see Figure 2). Although there are many algorithms
for these functions, I included three common algorithms
so as to observe how well the integrated architecture can
perform. Nevertheless, it is optional that replacing these
algorithms with others which conform to these functions.
Here, Chi2 algorithm serves as the selector to systemati-
cally extract the relative important genes so as to reduce
the dimension and retain as much as possible of the class
discriminatory information. This selector can also provide
the consistency of data to the other functions, the input
data flows of which come from the output data flows of
the selector. Subsequently, diagonal quadratic discrimi-
nant analysis (DQDA) was combined to discriminate
tumor classes. And generalized rule induction (GRI) was
integrated to establish association rules which can give an
understanding of the relationship between cancer classes
and influence genes. In addition, the outcomes obtained
from the three functions of selector, classification and rule
development can be referenced by each other. For exam-
ple, an accurate classification reveals the fact that the
A three-tiered architecture applied to microarray gene  expression data to integrate the tasks of data analysis from  the pre-processing to the data mining Figure 1
A three-tiered architecture applied to microarray 
gene expression data to integrate the tasks of data 
analysis from the pre-processing to the data mining.
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The X-AI framework with dataflow for cancer classification  and knowledge acquisition from DNA microarray data Figure 2
The X-AI framework with dataflow for cancer classi-
fication and knowledge acquisition from DNA micro-
array data.
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selected features are effective, which generally makes the
developed rules more reliable.
Chi2 algorithm
The Chi2 algorithm [25] can discretize numeric features
and select relevant features according to the chi-squared
statistic with respect to the class. The chi-squared value of
an attribute is calculated as the following equation,
where k is the number of classes and Aij the number of
samples of the j-th class in the i-th interval. Eij means the
expected frequency of Aij, which is calculated by
where Ri is the number of samples in the i-th interval, Cj
the number of samples in the j-th class, n the total number
of samples. The algorithm mainly consists of two phases,
named Phase I and II. Phase I comprises the calculation of
the chi-squared value for adjacent intervals, and the merge
of adjacent intervals under a chi-squared threshold which
will be decrementing until an inconsistency rate of data is
exceeded; Phase II includes the finer process of Phase I for
each feature, and the evaluation of the merge degree
which reveals the relevant feature to data. For example, a
feature is regarded as an irrelevance for data if it is merged
to only one value at the end of Phase II.
In this work, I have applied the algorithm to two different
datasets to analyze the relative importance of genes for the
discrimination of tumor classes. And it was chiefly carried
out from a suit of free open-source software [26], which
provides numerous machine learning algorithms from
various learning paradigms.
Diaquadratic discriminant analysis (DQDA)
Based on Bayes decision theory, the maximum likelihood
(ML) discriminant rule discriminates the class of a feature
vector x by assigning the one which yields maximal likeli-
hood [27]. For multivariate Gaussian distributions, the
likelihood function of ωi with respect to x in the l-dimen-
sional feature space is given by
where μi is the mean of x for the ωi class, Σi the l by l cov-
ariance matrix. When the covariance matrices are diago-
nal,  , the ML discriminate rule can
be written as
, which is a
special case of diagonal quadratic discriminant analysis
(DQDA). In practice, μi and  Σi are estimated by corre-
sponding sample quantities. we have effectively utilized it
for the analysis of discriminating two- and three-state pro-
teins [28]. In this study, the combination of selected genes
was used as the feature vector to discriminate tumor
classes.
Generalized rule induction (GRI)
Generalized rule induction was proposed by Smyth and
Goodman [29], which applies an information theoretic
approach to automate rule acquisition. For a rule, if ante-
cedent then consequent, GRI applies J-measure quantifies its
information content:
where  p(a) represents the probability of the observed
attribute value of a, as a measure of the coverage of the
antecedent;  p(c) represents the prior probability of the
value of c, as a measure of the common of the observed
attribute value of c in the consequent; p(c|a) represents an
modified probability of observing this value of c after tak-
ing into account the additional information of the value
of a. For rules with more than one antecedent, p(a) is
regarded as the probability of the conjunction of the vari-
able values in the antecedent. Accordingly, a set of opti-
mal rules was then generated by ITRULE algorithm, which
calculates  J-measures of rules by employing depth-first
search over possible left-hand sides.
Here, the genes selected by Chi2 algorithm were consid-
ered as the attributes of the antecedent. And the tumor
class was the only attribute of the consequent.
Performance evaluation and test procedure
Prediction accuracy
I considered the classification of the leukemia datasets L1
and L2 as the two-class and three-class problems, respec-
tively. To evaluate the performance of the classification
problems, both classification accuracy and misclassified
number were calculated along with corresponding
number of selected genes.
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Support and confidence
The support and confidence measures were defined to
reveal the importance of individual association rule. For a
particular association rule, support is the proportion of
samples in the dataset that contain the rule antecedent:
This measure reveals the comprehensiveness of the rule to
the dataset.
Further, confidence of the association rule is a measure of
accuracy of the rule:
Holdout validation and leave-one-out cross-validation tests
The present method was validated by both holdout vali-
dation and leave-one-out cross-validation (LOOCV) tests.
Holdout validation derives a predictor from the training
set, and uses the blind or independent test set to evaluate
the predictor. LOOCV is simple n-fold cross-validation,
where n is the number of samples in the dataset. Each
sample is left out in turn, and the predictor is trained on
all the remaining ones. The procedure is repeated for n
times to obtain a mean score.
Results and discussions
Analysis of important genes
X-AI provides a feature selection function to systemati-
cally extract the relative important genes for discriminat-
ing different classes. In Table 1, the top ten genes for each
training set of two datasets are listed according to the
order of the chi-squared statistic. The selected genes pro-
vide input information to both subsequent functions of
classification and rule development, and the small
number of selected genes has a low data dimension, as
well as low calculation complexity. Nevertheless, the deci-
sion of the nmber is flexible and largely depends on the
analysis requirement.
In the part of L1, the importance of most genes has been
discussed in the study of Golub et al. [1] and in earlier lit-
eratures. Further, Wang et al. [30] also presented addi-
tional arguments about Zyxin and PTX3, suggesting that
the expression level of both plays an important or
neglected role in distinguishing between ALL and AML.
The selection function of X-AI has also been compared
with some other selection algorithms, including informa-
tion gain and symmetrical uncertainty criteria. It showed
an almost the same selection in the top ten genes. In the
part of L2, the average of chi-squared values is higher than
that in L1. The results indicate that most of genes extracted
by the selection function of X-AI agrre with earlier studies,
and may be important for the class discrimination.
support =
number of samples containing antecedent
total number r of samples
.
(5)
confidence =
number of samples containing both antecedent and d concequent
number of samples containing antecedent
.
(6)
Table 1: Top ten genes selected by feature selection function of X-AI for two datasets
Dataset Probe ID Gene annotation χ2 Score
L1 X95735 Zyxin 38.00
M55150 FAH Fumarylacetoacetate 33.54
M27891 CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage) 33.31
M31166 PTX3 Pentaxin-related gene, rapidly induced by IL-1 beta 33.31
X70297 CHRNA7 Cholinergic receptor, nicotinic, alpha polypeptide 7 29.77
U46499 GLUTATHIONE S-TRANSFERASE, MICROSOMAL 29.77
L09209_s APLP2 Amyloid beta (A4) precursor-like protein 2 29.77
M77142 NUCLEOLYSIN TIA-1 29.77
J03930 ALKALINE PHOSPHATASE, INTESTINAL PRECURSOR 29.02
M23197 CD33 CD33 antigen (differentiation antigen) 28.95
L2 36239_at H. sapiens mRNA for oct-binding factor 91.08
37539_at Homo sapiens mRNA for KIAA0959 protein, partial cds 84.51
35260_at Homo sapiens mRNA for KIAA0867 protein, complete cds 83.72
32847_at Homo sapiens myosin light chain kinase (MLCK) mRNA, complete cds 79.82
35164_at Homo sapiens transmembrane protein (WFS1) mRNA, complete cds 79.46
1325_at Homo sapiens TWIK-related acid-sensitive K+ channel (TASK) mRNA, complete cds 78.57
40191_s_at wg66h09.x1 Homo sapiens cDNA, 3' end 77.22
39318_at H. sapiens mRNA for Tcell leukemia 76.22
32579_at Human transcriptional activator (BRG1) mRNA, complete cds 74.97
41715_at H. sapiens mRNA for phosphoinositide 3-kinase 73.53
L1: the dataset of Golub et al. [1]
L2: the dataset of Armstrong et al. [20]Journal of Biomedical Science 2009, 16:25 http://www.jbiomedsci.com/content/16/1/25
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Prediction performance of system
Different tests have been applied to verify the accuracy of
the classification function of X-AI. For holdout validation
test, it shows the accuracy of 96% and 99% on the test sets
of L1 and L2, respectively, using the ten genes as input
information. I have also carried out the analysis of classi-
fication accuracy along with the corresponding number of
genes by holdout validation test. Figure 3 illustrates the
classification accuracy as a function of the number of
selected genes. The genes were one by one included as the
input information according to the order of chi-squared
statistic. On the test set of dataset L1, X-AI achieves an
accuracy of 98.6% using two genes, and increasing the
number of genes to 10 did not further improve it. In addi-
tion, on the test set of dataset L2, the accuracy can increase
to 100% using eight genes. On the one hand, the training
and test sets for each dataset were combined to form a
complete dataset for LOOCV test. The test yielded the
accuracy of 96% and 94% for datasets L1 and L2, respec-
tively.
The results show that the classification function performs
well in discriminating these different classes when the
input information is provided by the feature selector func-
tion of X-AI. Namely, the integration of the both functions
can be feasible and effective for the binary classification
and three-class problems.
Comparison with other methods
The performance comparison between X-AI and other
methods has also been made on different datasets. The
results provide an overall view about the performance of
different methods. In Figure 4, the prediction perform-
ance is tested on dataset L1 by holdout validation. These
compared methods include the weighted voting machine,
which is based on a linear model [1]; support vector
machines (SVM) [31]; the emerging patterns algorithm
[32]; maximal margin linear programming (MAMA) [33];
four methods that combine the feature selector with
machine learning algorithms [30] and six methods which
have been discussed in earlier literature [34]. The numbers
of misclassified samples and of used genes vary from 0 to
5 and 1 to 132, respectively. This analysis shows that other
methods can not dominate X-AI simultaneously on the
numbers of misclassified samples and of used genes;
namely, X-AI has a relatively small number of misclassi-
fied samples or used genes.
Figure 5 shows the comparison of prediction performance
on dataset L2. the classification based on correlation/
ordering network [35] showed an accuracy of 100% using
information of 40 genes. Other seven compared methods
include three TSP-family classifiers and five machine
learning methods: C4.5 decision trees (DT), Naïve Bayes
(NB),  k-nearest neighbor (k-NN), SVM and prediction
analysis of microarrays (PAM) [19]. The accuracy and the
number of used genes vary from 80% to 100% and 2 to
12582, respectively. The analysis reveals that X-AI can
achieve a relatively high accuracy using a small number of
informative genes when comparing to these methods.
Association rule development
The function of feature selection did not only reduce the
number of input genes, but also improve the efficiency of
rule development. It also results in a rational and accept-
able number of rules. Based on the genes of Table 1, X-AI
included all the samples for each dataset to establish asso-
ciation rules.
Tables 2 and 3 list all association rules that developed for
each dataset and class. The average confidence is 99% and
97% for datasets L1 and L2, respectively, showing the high
accuracy of these rules. In Table 2, the second rule means
that if the expression of M23197 (CD33) is larger than 401.5,
then the sample is classified as ALL. For dataset L1, 29.17%
samples contain the antecedent of this rule and all these
samples are correctly classified. This rule efficiently reveals
the importance of the gene in discriminating between
Prediction performance of X-AI along with different number  of genes on the test set of two datasets Figure 3
Prediction performance of X-AI along with different 
number of genes on the test set of two datasets. The 
y-axis represents classification accuracy and the x-axis is the 
corresponding number of genes which were used as informa-
tion in classification. L1: for the dataset of Golub et al. [1] L2: 
for the dataset of Armstrong et al. [20]
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Comparison of prediction performance between different methods Figure 4
Comparison of prediction performance between different methods. The y-axis denotes the number of samples which 
were misclassified by those methods on the test set of L1. The number of used genes is represented in the x-axis. Voting 
machine [1] SVM [31] Emerging patterns [32] MAMA [33] J48, NB, SMO-CFS, SMO-Wrapper [30] RIRLS, RPLS, RPCR, FPLS, 
MAVE, k-NN [34]
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AML and ALL. This finding is in accord with the results of
earlier studies [1,19]. Further, I observed the occurrence of
genes among the rules, which may related to their impor-
tance. Interestingly, the gene X95735 (Zyxin) has a high-
est percentage of occurrence (30%) and Wang et al. [30]
also gave a detailed discussion about its role in leukemia.
In Table 3, the gene 1325_at (TASK) also has a high per-
centage of occurrence (24%). However, it may need more
comparative studies for validation.
Web server for cancer classification
I have also developed a web server for classifying tumors
of acute leukemia and it is freely available at http://bioin
formatics.myweb.hinet.net/xai.htm. The prediction can
be made by taking four simple steps (see Figure 6): (i)
select "Prediction" from the main page to open an input
subpage, (ii) select a set of input genes, (iii) input the
expression values for each gene, and (iv) press the "Sub-
mit" button to start the service.
Because X-AI selected two different sets of input genes
from two datasets for training the classifiers, it results in
two classifiers with different sets of input genes. Users can
optionally assign one of both to predict cancer classes. In
addition to the cancer classification page, the web server
has provided help and reference pages for interested
researchers.
Conclusion
In this study, I have proposed an integrated method for
accurate cancer classification, relevant gene selection, and
the associate rule development from DNA microarray
data. Applying the concepts of system design, the modules
Table 2: Two different classes of rules generated from dataset L1
Consequent Antecedent Support (%) Confidence (%)
ALL L09209_s > 1056.5 & M23197 > 326.0 30.56 100
M23197 > 401.5 29.17 100
M27891 > 2096.5 27.78 100
X95735 > 994.0 & M55150 > 1250.5 27.78 100
X95735 > 994.0 36.11 92
AML U46499 < 154.5 59.72 100
L09209_s < 992.5 58.33 100
X95735 < 994.0 63.89 98
Mean 41.67 99
Table 3: Three different classes of rules generated from dataset L2
Consequent Antecedent Support (%) Confidence (%)
ALL 32847_at > 147.0 30.56 100
36239_at > 2201.0 27.78 100
AML 39318_at < 1063.0 & 32579_at < 2285.0 34.72 100
1325_at < 1501.5, 39318_at < 1063.0 & 32579_at < 2285.0 34.72 100
1325_at < 1501.5, 36239_at < 214.0 & 40191_s_at < 508.5 33.33 100
36239_at < 214.0 & 40191_s_at < 508.5 33.33 100
39318_at < 1063.0 & 35164_at < -794.5 31.94 100
40191_s_at < 519.0 & 36239_at < 167.0 31.94 100
1325_at < 1501.5, 39318_at < 1063.0 & 35164_at < -794.5 31.94 100
1325_at < 1501.5, 40191_s_at < 519.0 & 36239_at < 167.0 31.94 100
1325_at < 1501.5, 36239_at < 214.0 & 37539_at < -362.0 31.94 100
36239_at < 214.0 & 37539_at < -362.0 31.94 100
37539_at < -725.5 29.17 100
32579_at < 2285.0 36.11 96
1325_at < 1501.5 & 32579_at < 2285.0 36.11 96
36239_at < 214.0 40.28 93
MLL 1325_at < 201.0, 35260_at > 794.5 & 40191_s_at > 1107.5 19.44 100
1325_at < 201.0 & 36239_at > 214.0 23.61 94
1325_at < 201.0 37.50 67
Mean 32.02 97Journal of Biomedical Science 2009, 16:25 http://www.jbiomedsci.com/content/16/1/25
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in the present architecture are tight cohesion and loose
coupling.
Through different tests, the method shows high classifica-
tion accuracy on two leukemia datasets. In addition, the
selected genes and the generated rules are in accord with
recent studies. The results suggest that the method can
effectively integrate these related functions for the analysis
of microarray data.
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